You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MDGL Exercise Disclosure
Sibold William John · SEC Form 4 · Filed Jul 20, 2026
Exercise
Reported value range
Not reported
Sibold William John President And CEO
MDGL
Transaction date
Jul 17, 2026
Public filing date
Jul 20, 2026
Filing lag
Filed 3 days later
MDGL daily price context
Close on/before transaction
$553.48
Jul 17, 2026
First close after public filing
$546.79
Jul 21, 2026
30-day return after filing
-1.21%
Through Aug 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 50,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-048919
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.37M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $25.8K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $296.87K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $59.82K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $550.72 |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $147.16K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $372.43K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $84.15K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $75.98K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $155.41K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Jul 20, 2026 | $150.07K |
| Madrigal Pharmaceuticals, Inc. MDGL | Exercise | Jul 17, 2026 | $0 |
| Madrigal Pharmaceuticals, Inc. MDGL Current | Exercise | Jul 17, 2026 | Not reported |